キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/06/20 | 4,130 | 4,150 | 4,075 | 4,110 | -20 | -0.5% | 144,300 |
2025/06/19 | 4,140 | 4,145 | 4,090 | 4,130 | -10 | -0.2% | 62,500 |
2025/06/18 | 4,115 | 4,145 | 4,110 | 4,140 | -5 | -0.1% | 34,800 |
2025/06/17 | 4,150 | 4,190 | 4,120 | 4,145 | -55 | -1.3% | 53,000 |
2025/06/16 | 4,235 | 4,235 | 4,145 | 4,200 | +20 | +0.5% | 58,800 |
2025/06/13 | 4,200 | 4,270 | 4,165 | 4,180 | -20 | -0.5% | 117,100 |
2025/06/12 | 4,170 | 4,215 | 4,135 | 4,200 | ±0 | ±0% | 69,900 |
2025/06/11 | 4,190 | 4,245 | 4,185 | 4,200 | +10 | +0.2% | 77,900 |
2025/06/10 | 4,185 | 4,205 | 4,170 | 4,190 | -25 | -0.6% | 47,100 |
2025/06/09 | 4,205 | 4,250 | 4,195 | 4,215 | +45 | +1.1% | 78,500 |
2025/06/06 | 4,255 | 4,255 | 4,145 | 4,170 | -30 | -0.7% | 59,300 |
2025/06/05 | 4,235 | 4,235 | 4,175 | 4,200 | -35 | -0.8% | 44,300 |
2025/06/04 | 4,190 | 4,290 | 4,180 | 4,235 | +5 | +0.1% | 67,500 |
2025/06/03 | 4,230 | 4,260 | 4,185 | 4,230 | +5 | +0.1% | 110,100 |
2025/06/02 | 4,250 | 4,285 | 4,190 | 4,225 | -65 | -1.5% | 169,600 |
2025/05/30 | 4,050 | 4,300 | 4,050 | 4,290 | +330 | +8.3% | 296,000 |
2025/05/29 | 3,915 | 3,985 | 3,900 | 3,960 | +45 | +1.1% | 73,000 |
2025/05/28 | 3,940 | 3,985 | 3,900 | 3,915 | +25 | +0.6% | 79,400 |
2025/05/27 | 3,875 | 3,915 | 3,875 | 3,890 | ±0 | ±0% | 41,200 |
2025/05/26 | 3,900 | 3,960 | 3,890 | 3,890 | +35 | +0.9% | 63,200 |
2025/05/23 | 3,865 | 3,890 | 3,840 | 3,855 | -10 | -0.3% | 69,200 |
2025/05/22 | 3,850 | 3,885 | 3,840 | 3,865 | -25 | -0.6% | 55,800 |
2025/05/21 | 3,885 | 3,920 | 3,850 | 3,890 | +5 | +0.1% | 62,200 |
2025/05/20 | 3,930 | 3,935 | 3,870 | 3,885 | -10 | -0.3% | 65,400 |
2025/05/19 | 3,835 | 3,915 | 3,815 | 3,895 | +90 | +2.4% | 97,500 |
2025/05/16 | 3,820 | 3,860 | 3,770 | 3,805 | +20 | +0.5% | 93,400 |
2025/05/15 | 3,780 | 3,820 | 3,760 | 3,785 | +5 | +0.1% | 69,900 |
2025/05/14 | 3,905 | 3,960 | 3,750 | 3,780 | -160 | -4.1% | 114,400 |
2025/05/13 | 4,040 | 4,045 | 3,920 | 3,940 | -85 | -2.1% | 154,300 |
2025/05/12 | 4,110 | 4,135 | 3,925 | 4,025 | -130 | -3.1% | 161,100 |
2025/05/09 | 3,940 | 4,215 | 3,930 | 4,155 | +180 | +4.5% | 227,500 |
2025/05/08 | 4,200 | 4,200 | 3,880 | 3,975 | +165 | +4.3% | 659,300 |
2025/05/07 | 3,795 | 3,835 | 3,750 | 3,810 | +15 | +0.4% | 115,200 |
2025/05/02 | 3,795 | 3,830 | 3,775 | 3,795 | ±0 | ±0% | 75,200 |
2025/05/01 | 3,770 | 3,795 | 3,750 | 3,795 | +50 | +1.3% | 61,300 |
2025/04/30 | 3,750 | 3,755 | 3,705 | 3,745 | +45 | +1.2% | 76,800 |
2025/04/28 | 3,715 | 3,745 | 3,690 | 3,700 | -25 | -0.7% | 66,500 |
2025/04/25 | 3,780 | 3,795 | 3,720 | 3,725 | -50 | -1.3% | 38,900 |
2025/04/24 | 3,850 | 3,895 | 3,775 | 3,775 | -70 | -1.8% | 67,700 |
2025/04/23 | 3,850 | 3,860 | 3,815 | 3,845 | +10 | +0.3% | 58,200 |
2025/04/22 | 3,790 | 3,890 | 3,785 | 3,835 | +55 | +1.5% | 77,000 |
2025/04/21 | 3,730 | 3,795 | 3,715 | 3,780 | +70 | +1.9% | 58,800 |
2025/04/18 | 3,650 | 3,740 | 3,615 | 3,710 | +115 | +3.2% | 73,000 |
2025/04/17 | 3,580 | 3,600 | 3,560 | 3,595 | +15 | +0.4% | 47,600 |
2025/04/16 | 3,635 | 3,645 | 3,560 | 3,580 | -55 | -1.5% | 71,700 |
2025/04/15 | 3,650 | 3,670 | 3,630 | 3,635 | ±0 | ±0% | 38,900 |
2025/04/14 | 3,600 | 3,675 | 3,590 | 3,635 | +95 | +2.7% | 68,900 |
2025/04/11 | 3,540 | 3,550 | 3,480 | 3,540 | -135 | -3.7% | 86,000 |
2025/04/10 | 3,660 | 3,695 | 3,630 | 3,675 | +85 | +2.4% | 130,400 |
2025/04/09 | 3,595 | 3,680 | 3,560 | 3,590 | -60 | -1.6% | 107,600 |
1~
50
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 411,000円 | +3.6% | +6.1% | 2.92% | 13.85倍 | 0.81倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ペプチド | 163,300円 | +5.0% | +1.5% | 0.00% | 13.97倍 | 3.72倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 274,100円 | - | - | 0.00% | - | 126.96倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
市場注目の銘柄
チャート関連のコラム